SCHF vs XLV
Schwab International Equity ETF vs Health Care Select Sector SPDR Fund
- • SCHF has the lower expense ratio at 0.03% vs 0.08% for XLV.
- • SCHF pays a higher dividend yield (3.06%).
Side-by-side metrics
| Metric | SCHF | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.08% |
Dividend yield Trailing 12-month yield. | 3.06% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $66.22B | $40.60B |
YTD return | 14.21% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 0.51 |
P/E ratio | 18.95 | 29.12 |
Last price | $27.52 | $161.81 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHF top holdings
| 005930.KS | Samsung Electronics Co Ltd | 3.27% |
| 000660.KS | SK Hynix Inc | 3.19% |
| ASML.AS | ASML Holding NV | 2.41% |
| HSBA.L | HSBC Holdings PLC | 1.10% |
| NOVN.SW | Novartis AG Registered Shares | 0.99% |
| RY | Royal Bank of Canada | 0.97% |
| AZN.L | AstraZeneca PLC | 0.96% |
| NESN.SW | Nestle SA | 0.91% |
| SIE.DE | Siemens AG | 0.76% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About SCHF
SCHF (Schwab International Equity ETF) is Developed-market equities ex-US. Managed by Schwab, the fund carries $66.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 3.06%. Its largest holding is Samsung Electronics Co Ltd (005930.KS), which represents 3.3% of the portfolio. Real Estate is the fund's largest sector exposure at 2.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.